Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03324880
Recruitment Status : Recruiting
First Posted : October 30, 2017
Last Update Posted : January 11, 2021
Sponsor:
Information provided by (Responsible Party):
Takeda ( Shire )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 24, 2021
Estimated Study Completion Date : June 30, 2022